Dr. Hamzah Nsour
OP01 - Autoinflammation vs Autoimmunity in 3 Children: What is the Definitive...
Dr. Nour Jafal & Dr. Banan Ateeq
OP03 - Clinical Spectrum and Management Challenges: A Case Series of Eleven P...
Dr. Baraa Abuhameda
OP05 - Mucolipidosis Type III in Two Consanguineous Families: A Metabolic Mim...
Opening Ceremony
Dr. Mahdi Abu Salamah
L02 - LVV with Focus on Takayasu — Management Update
Dr. Jamal Steitieh
L04 - Rheumatologists and Autoimmune Reproductive Failure
Dr. Mohammad Alnoubani
L06 - Monogenic SLE in Children
Dr. Mohammed Abu-Shukair
L08 - Practical Approach to Periodic Fever Syndromes
Dr. Marwan Adwan
L010 - SLE Mortality in a Homogeneous Arab Cohort
Dr. Hadi Rabee
L012 - Obinutuzumab in lupus!
Dr. Adel Wahadne
L014 - From Autoimmunity to Primary Immunodeficiency: Ten Overlooked Case Sce...
Dr. Fatima Alnaimat
L016 - From Cohorts to Care: Tracking Two Decades of Scleroderma Characterist...
Dr. Saed Atawnah
L018 - Management of Interstitial Lung Disease in Rheumatic Diseases
Dr. Isam Alhindi
L020 - Inflammatory Bone Disease
Dr. Fadi Kharouf
L022 - Psoriatic Dactylitis: The Association with HLA Genetic Susceptibility...
Dr. Mohammad Adawi
L024 - The Influence of Environmental and Genetic Factors on the Development...
Dr. Sufian Rifaei
L026 - Sjogren’s Syndrome: A Review of Recent Advances in Diagnosis and Therapy
Dr. Muaath Itmaizeh
L028 - Behçet’s Disease Causing Pulmonary Artery Aneurysm: Review of Management
Dr. Sura Alhunifat
OP02 - Real-world Safety Outcomes of Biological Therapy in Pediatric Juvenile...
Dr. Anas Odat
OP04 - A Child with Rash and Painful Joints
Dr. Zain Aldeen Saleh
OP06 - Long-term use of Proton Pump Inhibitors and the Risk of Osteoporosis
Dr. Basel Masri
L01 - Update on Anabolic Agents Indication for Osteoporosis
Dr. Kasser Aldaow
L03 - Secondary Adrenal Insufficiency Following Corticosteroid Therapy in Rhe...
Dr. Sima Abu Al-Saoud
L05 - MASKed Danger: Timely Recognition and Management of Macrophage Activati...
Dr. Fawzy Mazen Abunejma Al Tamimi
L07 - Understanding PFAPA Syndrome in Palestine: a retrospective cohort analy...
Dr. Motasem Alsuweiti
L09 - Biological Agents Switching in Pediatric Rheumatology, Insights from a...
L011 - Is Antimalarial Use Associated with a Reduced Risk of Lupus Nephritis...
Dr. Kamel Mroueh
L013 - CAR T-cell: A New Mode of Therapy for Autoimmune Rheumatic Diseases
Dr. Majed Aboud
L015 - Stem Cells for Autoimmune Disorders
Dr. Suhad Al Qurashi
L017 - Myositis-associated ILD
Dr. Nizar Abdulateef
L019 - IgG4-Related Disease in the Real World: A Rheumatology Clinic Perspective
Dr. Laith Alamleh
L021 - Diagnostic Delay in Axial Spondyloarthritis
Dr. Musa Hadidi
L023 - Updates on Early Rheumatoid Arthritis
Dr. Jessica Nicolas
L025 - Neuroinflammation and Immunological Aspect of Fibromyalgia
Dr. Wafa Madanat
L027 - Behçet’s Disease: A Diagnostic Challenge in Rheumatology
